1 not yet recruiting. .
Follow SSTR-expressing Tumors: new trials by email Literature Review of SSTR-expressing Tumors trials Research Report on SSTR-expressing Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies 68Ga-DOTATATE PET/CT, 18F-AmBF3-TATE PET/CT - Neuroendocrine Tumors, NET, Pheochromocytoma/Paraganglioma | Not yet recruiting | British Columbia Cancer Agency | 60 | 2026-11-30 | 2026-10-06 |
Carcinoma, Medullary (1) · Neuroendocrine Tumors (1) · Paraganglioma (1) · Pheochromocytoma (1)
Adenocarcinoma (1) · Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Ductal, Lobular, and Medullary (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1)
British Columbia Cancer Agency (1)
Canada (1)